Key Points
- OpenAI generated $10 billion in third-quarter revenue—a roughly 50% sequential jump—while posting an operating loss of $10.9 billion driven by intense compute and R&D costs.
- Cumulative operating losses topped $32 billion for the first nine months of 2026, intensifying public market scrutiny as rival Anthropic advances its own multi-billion-dollar listing.
- For international allocators and Israeli tech investors, the figures highlight widening multiple dispersion between capital-intensive foundation models and cash-generative application software.
OpenAI grew third-quarter revenue by approximately 50% sequentially to $10 billion, but continued to record severe bottom-line deficits as operating losses widened to $10.9 billion, according to financial figures reported by The Wall Street Journal. The results push the ChatGPT developer’s cumulative nine-month operating deficit beyond $32 billion, reflecting massive expenditure on advanced frontier model training, high-bandwidth compute clusters, and non-cash equity compensation. Arriving amid an overarching valuation recalibration across global technology bourses and benchmark 10-year Treasury yields hovering near 4.90%, the disclosures demonstrate that explosive enterprise demand has yet to neutralize the extreme capital intensity required to build frontier artificial intelligence.
Accelerating Enterprise Monetization Collides With Expanding Cloud Liabilities
The third-quarter revenue milestone of $10 billion underscores formidable commercial adoption, climbing from $5.7 billion in the first quarter and $6.7 billion in the second. Growth was propelled by corporate API consumption, enterprise licensing tiers, and recurring ChatGPT subscriptions across multinational organizations. However, the cost of revenue—primarily infrastructure fees paid to cloud hosts for live model inference—alongside dedicated research and development outlays expanded at a comparable rate, resulting in the quarterly operating deficit climbing to $10.9 billion.
The persistent burn rate highlights the structural mechanics of foundation-model economics. Although OpenAI secured substantial private funding earlier this year to construct a robust liquidity buffer, internal projections indicate that negative cash flow could persist until the end of the decade as training runs for reasoning architectures scale into tens of billions of dollars. While cash burn remains well below headline accounting losses due to the inclusion of stock-based compensation, the necessity of continuously purchasing cutting-edge accelerator capacity leaves gross margins tightly constrained compared to traditional enterprise software platforms.
Peer Comparison and Structural Repercussions for Israeli Allocators
The widening deficit sharpens the competitive contrast with primary rival Anthropic, which recently outlined terms for a blockbuster public debut targeting up to $69.3 billion on $17 billion in third-quarter revenue. Whereas Anthropic has demonstrated narrower operating losses and targeted near-term adjusted operating profitability, OpenAI’s $10.9 billion quarterly loss reinforces investor concerns that consumer-facing model providers must absorb massive unmetered inference overhead. With OpenAI targeting a potential 2027 initial public offering at a valuation exceeding $1 trillion, public institutional desks are scrutinizing whether revenue growth alone can justify sustained double-digit quarterly deficits.
For Israeli institutional pension managers and asset allocators on the Tel Aviv Stock Exchange (TASE), the disclosures provide actionable guidance for portfolio construction. Israel’s tech ecosystem features hundreds of high-growth startups leveraging foundational models via API to deliver vertical solutions in cybersecurity, fintech, and medical diagnostics. Israeli fund managers are increasingly favoring these downstream enterprise software providers—which capture client software budgets without bearing direct multi-billion-dollar hardware and training liabilities. Furthermore, with the New Israeli Shekel (NIS) consolidating steadily near 3.14 per dollar, local multi-asset desks are pairing selective private equity tech allocations with high-yielding domestic government bonds (Shahar), avoiding speculative unhedged exposure to capital-depleting hardware consortia.
Outlook: Pricing Pressures, Hyperscaler Contracts, and IPO Milestone Tracking
Moving into 2027, market participants will monitor whether OpenAI can improve unit economics through enhanced inference efficiency and revised hyperscaler hosting agreements. Critical metrics to track include average revenue per enterprise seat, the cadence of price cuts in response to open-weight model competition, and whether management begins curbing discretionary R&D ahead of formal audited S-1 filings. If sequential revenue continues to surge while compute costs flatten, OpenAI could establish a credible timeline toward cash-flow breakeven; however, continued double-digit billion-dollar operating losses will test public market valuation thresholds as listing dates approach.
Comparison, examination, and analysis between investment houses
Leave your details, and an expert from our team will get back to you as soon as possible
* This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.
To read more about the full disclaimer, click here- orshu
- •
- 7 Min Read
- •
- ago 3 hours
SKN | CoreWeave Beats Revenue Estimates and Raises Forecast as AI Demand Holds Firm
Strong Demand Supports Higher Forecasts CoreWeave exceeded Wall Street's quarterly revenue estimates and raised its annual forecasts on Tuesday, providing
- ago 3 hours
- •
- 7 Min Read
Strong Demand Supports Higher Forecasts CoreWeave exceeded Wall Street's quarterly revenue estimates and raised its annual forecasts on Tuesday, providing
- Lior mor
- •
- 6 Min Read
- •
- ago 5 hours
SKN | J&J Caplyta Shows Second Positive Trial Result for Bipolar Mania
Second Study Strengthens Regulatory Case Johnson & Johnson reported that Caplyta met the main objective in its second late-stage study
- ago 5 hours
- •
- 6 Min Read
Second Study Strengthens Regulatory Case Johnson & Johnson reported that Caplyta met the main objective in its second late-stage study
- sagi habasov
- •
- 7 Min Read
- •
- ago 23 hours
SKN | Skydance Targets $6 Billion in Synergies and Sets 2027 Streaming Bundle: Will Scale Fix Legacy Media’s Balance Sheet?
Skydance Media announced an aggressive post-merger integration blueprint on Monday, November 9, 2026, committing to achieve at least $6 billion
- ago 23 hours
- •
- 7 Min Read
Skydance Media announced an aggressive post-merger integration blueprint on Monday, November 9, 2026, committing to achieve at least $6 billion
- Articles
- •
- 6 Min Read
- •
- ago 1 day
SKN | Eli Lilly’s Foundayo Reduces Sleep Apnea Symptoms in Late-Stage Trial
Foundayo Meets Primary Goal in Sleep Apnea Study Eli Lilly reported positive results from a late-stage clinical trial evaluating its
- ago 1 day
- •
- 6 Min Read
Foundayo Meets Primary Goal in Sleep Apnea Study Eli Lilly reported positive results from a late-stage clinical trial evaluating its